| 51 |
17393691 | [Role of angiotensin II receptors in proliferation of fibroblast derived from human hypertrophic scars]. | 2007 Jan |
1 |
| 52 |
17702736 | Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals. | 2007 Sep |
1 |
| 53 |
17715979 | Synthesis of valsartan via decarboxylative biaryl coupling. | 2007 Sep 14 |
2 |
| 54 |
17785354 | Angiotensin II regulates adipocyte apolipoprotein E expression. | 2007 Nov |
1 |
| 55 |
17875818 | Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells. | 2007 Nov |
1 |
| 56 |
17964282 | Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysis. | 2007 Dec 28 |
1 |
| 57 |
15896827 | Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. | 2006 |
1 |
| 58 |
16513451 | The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. | 2006 Mar |
4 |
| 59 |
16522324 | Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars. | 2006 Jun 27 |
3 |
| 60 |
17060512 | Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. | 2006 Dec |
1 |
| 61 |
15643130 | Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. | 2005 Jan |
5 |
| 62 |
15769395 | [Effects of angiotensin II on peripheral blood endothelial progenitor cells]. | 2005 Jan |
1 |
| 63 |
16042674 | Angiotensin II receptor blocker-induces blunted taste sensitivity: comparison of candesartan and valsartan. | 2005 Aug |
1 |
| 64 |
16134756 | The effects of valsartan on lipid profile in normotensive type 2 diabetic patients. | 2005 |
1 |
| 65 |
16206603 | [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)]. | 2005 |
2 |
| 66 |
16247790 | Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone. | 2005 Dec 1 |
1 |
| 67 |
19804097 | Valsartan: the past, present and future. | 2005 Sep |
2 |
| 68 |
14747881 | Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. | 2004 Feb |
1 |
| 69 |
15000294 | Short-term effects of exogenous angiotensin II on plasma fibrinolytic balance in normal subjects. | 2004 Jan |
1 |
| 70 |
15005273 | Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. | 2004 Feb |
1 |
| 71 |
15071355 | Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: a possible additional mechanism for clinical benefits. | 2004 May |
1 |
| 72 |
15579516 | Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. | 2004 Dec |
2 |
| 73 |
12799092 | Differential effect of acute angiotensin II type 1 receptor blockade on the vascular and adrenal response to exogenous angiotensin II in humans. | 2003 Jun |
1 |
| 74 |
12827025 | Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veins. | 2003 Jul |
1 |
| 75 |
12830992 | The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial in Slovakia. | 2003 |
1 |
| 76 |
12846741 | STAT proteins mediate angiotensin II-induced production of TIMP-1 in human proximal tubular epithelial cells. | 2003 Aug |
4 |
| 77 |
12876491 | Lymphomatoid drug eruption mimicking digitate dermatosis: cross reactivity between two drugs that suppress angiotensin II function. | 2003 Aug |
1 |
| 78 |
12970329 | Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. | 2003 Sep |
2 |
| 79 |
14761074 | Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. | 2003 Dec |
1 |
| 80 |
11963637 | [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data]. | 2002 Jan-Feb |
1 |
| 81 |
11967720 | Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors. | 2002 Apr |
2 |
| 82 |
12065072 | Interleukin-1 inhibits angiotensin II-stimulated protein kinase B pathway in renal mesangial cells via the inducible nitric oxide synthase. | 2002 May 10 |
1 |
| 83 |
12093312 | Angiotensin II receptor antagonists in chronic heart failure: where do they fit? | 2002 |
1 |
| 84 |
12361194 | Influence of AT1 receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patients. | 2002 |
2 |
| 85 |
12378864 | [Role of angiotensin II antagonists in the treatment of hypertension]. | 2002 |
1 |
| 86 |
12453539 | Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries. | 2002 Dec |
1 |
| 87 |
12652100 | Functional antagonism of different angiotensin II type I receptor blockers in human arteries. | 2002 Jul |
1 |
| 88 |
11244025 | Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells. | 2001 Mar |
4 |
| 89 |
11561217 | Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats. | 2001 Sep |
1 |
| 90 |
11561228 | Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects. | 2001 Sep |
1 |
| 91 |
11602816 | Central and peripheral effects of angiotensin II on the cardiovascular response to exercise. | 2001 Nov |
1 |
| 92 |
11881114 | Valsartan and candesartan can inhibit deteriorating effects of angiotensin II on coronary endothelial function. | 2001 Jun |
1 |
| 93 |
20428262 | Role of the angiotensin II receptor blocker valsartan in heart failure. | 2001 Winter |
1 |
| 94 |
10981149 | Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation. | 2000 Apr |
1 |
| 95 |
11019424 | [Diovan effectiveness in combined treatment of severe arterial hypertension]. | 2000 |
1 |
| 96 |
11131281 | Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells. | 2000 Nov |
6 |
| 97 |
11206708 | Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors. | 2000 Nov-Dec |
6 |
| 98 |
12555316 | [Tolerance to valsartan in office practice in 3,197 hypertensive patients (the VALSE study)]. | 2000 Feb |
2 |
| 99 |
17199210 | New basic science initiatives with the angiotensin II receptor blocker valsartan. | 2000 Jun |
3 |
| 100 |
17199217 | New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease. | 2000 Jun |
3 |